🇺🇸 FDA

Intelligence · Clinical Pipeline

Teva Pharma Pipeline

All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.

Programs
473

Quick answer

Teva Pharma has 473 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ACR16

    Teva Pharma GmbH

    Huntington's Disease

    phase 3 small molecule completed

    1 trial

  2. ACTIQ (Oral transmucosal fentanyl citrate)

    Teva Pharma GmbH

    Breakthrough Pain

    phase 3 small molecule completed

    1 trial

  3. Albuterol

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials

  4. Albuterol MDPI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  5. Albuterol Spiromax

    Teva Pharma GmbH

    Exercise-Induced Bronchoconstriction (EIB)

    phase 3 small molecule completed

    1 trial

  6. Albuterol Spiromax®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    4 trials

  7. Albuterol Sulfate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  8. Albuterol sulfate (ABS)

    Teva Pharma GmbH

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule completed

    1 trial

  9. Armodafinil

    Teva Pharma GmbH

    Traumatic Brain Injury

    phase 3 small molecule terminated

    2 trials

  10. Armodafinil

    Teva Pharma GmbH

    Excessive Daytime Sleepiness

    phase 3 small molecule completed

    1 trial

  11. Armodafinil

    Teva Pharma GmbH

    Narcolepsy

    phase 3 small molecule completed

    2 trials

  12. Armodafinil

    Teva Pharma GmbH

    Depression

    phase 3 small molecule completed

    4 trials

  13. Armodafinil 100 to 250 mg/day

    Teva Pharma GmbH

    Excessive Daytime Sleepiness

    phase 3 small molecule completed

    1 trial

  14. Armodafinil 150 mg/day

    Teva Pharma GmbH

    Excessive Sleepiness

    phase 3 small molecule completed

    1 trial

  15. Armodafinil 150 mg/day

    Teva Pharma GmbH

    Obstructive Sleep Apnea

    phase 3 small molecule completed

    1 trial

  16. Armodafinil 250 mg/day

    Teva Pharma GmbH

    Obstructive Sleep Apnea

    phase 3 small molecule completed

    1 trial

  17. Arsenic trioxide

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 3 small molecule terminated

    1 trial

  18. Arsenic trioxide

    Teva Pharma GmbH

    Acute Promyelocytic Leukemia

    phase 3 small molecule completed

    1 trial

  19. Azelastine hydrochloride and Fluticasone propionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial

  20. BDP

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  21. BDP HFA

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  22. BDP Nasal Aerosol

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  23. Balugrastim

    Teva Pharma GmbH

    Chemotherapy-induced Neutropenia

    phase 3 mab completed

    1 trial

  24. Beclomethasone Dipropionate 640

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  25. Beclomethasone dipropionate

    Teva Pharma GmbH

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  26. Beclomethasone dipropionate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials

  27. Beclomethasone dipropionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  28. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  29. Beclomethasone dipropionate breath-actuated inhaler

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  30. Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol

    Teva Pharma GmbH

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  31. Bendamustine HCl

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 small molecule completed

    1 trial

  32. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin Lymphoma

    phase 3 small molecule completed

    1 trial

  33. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  34. Budesonide/Formoterol SPIROMAX®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  35. Budesonide/Formoterol fumarate dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial

  36. CEP-10953 (Armodafinil)

    Teva Pharma GmbH

    Narcolepsy

    phase 3 small molecule completed

    1 trial

  37. CEP-1347 10mg

    Teva Pharma GmbH

    Parkinson Disease

    phase 3 small molecule terminated

    1 trial

  38. CEP-33457

    Teva Pharma GmbH

    Systemic Lupus Erythematosus

    phase 3 small molecule completed

    2 trials

  39. Carboplatin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 small molecule completed

    1 trial

  40. Cenestin 0.3 mg Tablets

    Teva Pharma GmbH

    Hot Flashes

    phase 3 small molecule completed

    1 trial

  41. Custirsen

    Teva Pharma GmbH

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  42. DR-1011

    Teva Pharma GmbH

    Contraception

    phase 3 small molecule completed

    1 trial

  43. DR-102

    Teva Pharma GmbH

    Contraception

    phase 3 small molecule completed

    1 trial

  44. DR-1021

    Teva Pharma GmbH

    Contraception

    phase 3 small molecule completed

    1 trial

  45. DR-1021

    Teva Pharma GmbH

    Healthy

    phase 3 small molecule completed

    1 trial

  46. DR-103

    Teva Pharma GmbH

    Pregnancy Prevention

    phase 3 small molecule completed

    1 trial

  47. DR-104

    Teva Pharma GmbH

    Emergency Contraception

    phase 3 small molecule completed

    1 trial

  48. DR-2011

    Teva Pharma GmbH

    Infertility

    phase 3 small molecule completed

    2 trials

Frequently asked questions

How many pipeline programs does Teva Pharma have?

473 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.